Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 120.70K | 4.80K | 12.20K | 186.60K | 4.10K |
| Total Receivables | 37.20K | 27.80K | 19.80K | 13.20K | 26.50K |
| Inventory | 47.70K | 7.70K | 7.60K | 7.60K | 7.60K |
| Prepaid Expenses | 50.40K | 56.10K | 89.20K | 123.80K | 27.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 256.00K | 96.30K | 128.70K | 331.10K | 65.30K |
|
|
|||||
| Total Current Assets | 256.00K | 96.30K | 128.70K | 331.10K | 65.30K |
| Net Property, Plant & Equipment | 1.59M | 1.62M | 1.57M | 1.55M | 1.52M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.00K | 10.40K | 10.30K | 10.30K | 10.30K |
| Total Assets | 1.85M | 1.73M | 1.70M | 1.89M | 1.59M |
|
|
|||||
| Total Accounts Payable | 648.80K | 371.20K | 271.20K | 686.10K | 160.60K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 11.70K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 834.40K | 618.60K | 479.40K | -- | 335.90K |
| Total Other Current Liabilities | 834.40K | 618.60K | 479.40K | -- | 335.90K |
| Total Current Liabilities | 1.49M | 989.80K | 750.60K | 686.10K | 496.50K |
|
|
|||||
| Total Current Liabilities | 1.49M | 989.80K | 750.60K | 686.10K | 496.50K |
| Long-Term Debt | 28.60K | 29.60K | 29.30K | 29.50K | 29.50K |
| Short-term Debt | 11.70K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.00K | 10.40K | 10.30K | 10.30K | 10.30K |
| Total Liabilities | 1.53M | 1.03M | 790.10K | 725.90K | 536.30K |
|
|
|||||
| Common Stock & APIC | 8.04M | 8.38M | 8.25M | 8.12M | 7.77M |
| Retained Earnings | -7.73M | -7.69M | -7.34M | -6.97M | -6.73M |
| Treasury Stock & Other | 14.90K | 13.20K | 9.80K | 9.50K | 8.60K |
| Total Common Equity | 321.20K | 700.10K | 914.40K | 1.16M | 1.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 321.20K | 700.10K | 914.40K | 1.16M | 1.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 321.20K | 700.10K | 914.40K | 1.16M | 1.06M |
|
|
|||||